Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Ex-Pfizer cancer drug shows mixed results in mid-stage studies
Ex-Pfizer cancer drug shows mixed results in mid-stage studies
Ex-Pfizer cancer drug shows mixed results in mid-stage studies
Submitted by
admin
on December 9, 2011 - 11:59am
Source:
Fierce Biotech
News Tags:
Pfizer
Puma Biotechnology
breast cancer
neratinib
PB272
Headline:
Ex-Pfizer cancer drug shows mixed results in mid-stage studies
Do Not Allow Advertisers to Use My Personal information
